Status note: As of the research date shown at the top of this page (), the most granular case breakdown located was ECDC's assessment. WHO's Disease Outbreak News remains the primary multinational announcement document dated .
What WHO reported on 4 May 2026
- WHO was notified on about a cluster of severe respiratory illness aboard a Dutch-flagged cruise ship.
- As of , seven cases (two laboratory confirmed for hantavirus and five suspected) had been identified, including three deaths, one critically ill patient, and three people reporting mild symptoms.
- Symptom onset ranged between and , with fever, gastrointestinal complaints, and rapid progression to pneumonia, acute respiratory distress syndrome, and shock described for severely affected patients.
- WHO stated the ship departed Ushuaia, Argentina, on , carrying 147 people (88 passengers and 59 crew) from 23 nationalities, followed South Atlantic routing with multiple remote stops, and as of 4 May was moored off Cabo Verde.
- WHO assessed global risk from the event as low while investigations—including sequencing—continued, and reminded readers that human infection usually follows rodent exposure while noting historically rare Andes virus person-to-person spread during close contact.
How ECDC updates refined laboratory details
- On , ECDC announced two laboratory-confirmed hantavirus infections plus one suspected case among 147 passengers and crew from 23 countries, with the ship off Cabo Verde; additional aspects (virus species, exact transmission route) were still under investigation.
- On , ECDC's formal assessment described seven reported cases in the cluster: three deaths, one critically ill patient medically evacuated to South Africa, two symptomatic individuals still on board, and one person diagnosed after returning to Switzerland. Two samples were PCR-positive for hantavirus and one additional sample PCR-positive for Andes virus, with further laboratory work ongoing.
- That same assessment noted 149 people on board from 23 nationalities—highlighting why readers should track primary sources for reconciled denominators as line lists are verified.
- ECDC outlined a working hypothesis that some travelers might have been exposed before embarkation in Argentina (where Andes virus circulates) with subsequent transmission possibilities on board given the closed environment, while stressing that confirmed person-to-person spread requires prolonged close contact for Andes virus.
Official response themes
WHO listed coordinated measures among Cabo Verde, the Netherlands, South Africa, Spain, and the United Kingdom: sharing passenger manifests with Argentine IHR focal points, advising maximal physical distancing on board, conducting epidemiologic investigations, evacuating severely ill patients, forwarding specimens to NICD South Africa and—with WHO logistical support—to Institut Pasteur de Dakar, and activating WHO emergency medical team discussions with the EU Emergency Response Coordination Centre for clinical evacuation capacity.
WHO passenger guidance published in the same Disease Outbreak News included 45 days of active symptom monitoring for travelers and crew, emphasis on hand hygiene, avoiding dry sweeping in favor of damp cleaning with ventilation, self-isolation when symptomatic, medical masking during respiratory symptoms, and immediate clinical evaluation if illness worsens.
How this differs from routine U.S. Sin Nombre risk
Travel-associated clusters differ from the classic rural, rodent-exposure risk messaging emphasized by CDC for Sin Nombre and other North American strains. Readers concerned about everyday prevention should still prioritize CDC's rodent exclusion and safe-cleaning guidance on the Stay Safe page; travelers who were present during this voyage should rely on instructions from their health authority and WHO updates rather than unofficial summaries.